...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Phase 1b/2 trial expected to initiate 1Q 2019
1
Mar 06, 2019 02:07PM

Mar 06, 2019 02:20PM
2
Mar 06, 2019 04:59PM
1
Mar 06, 2019 07:05PM
1
Mar 07, 2019 07:38AM
6
Mar 07, 2019 09:36AM
1
Mar 07, 2019 11:17AM
1
Mar 07, 2019 01:27PM

Bear,

This is a pretty long delay to get things started on this trial with Pfizer, you would think they would want to move quickly with the start of this trial ....  I wonder if more important things are getting finalized before they commence this trial,  just thinking out loud.....

Share
New Message
Please login to post a reply